Cervical Screening Programme, England, 2012-13: Graphs
Cervical Screening Programme, England, 2012-13: Graphs
1
Figure 1: Cervical screening – Five year coverage of the target age group (25-64)
England at 31st March, 2003 to 2013
© Data prior to 2005, re-used with the permission of the Department of Health.
Source: KC53, Health and Social Care Information Centre.
Figure 2: Cervical screening – Age appropriate coverage by age group
England, at 31st March, 2012 and 2013
Percent
2012
2013
100
90
80
70
60
50
40
30
20
10
63.0 62.0
72.7 70.6
76.1 73.7
78.1 75.8
78.3 76.2
82.8 82.4
76.6 75.9
72.7 72.7
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
0
25-49 (coverage <3.5 yrs since last test)
Source: KC53, Health and Social Care Information Centre.
50-64 (coverage <5 yrs since last test)
Figure 3: Cervical screening – Five year coverage of the target age group (25-64)
Primary Care Organisation (PCO), England, 31st March 2013
Number of PCOs
80
60
40
20
4
22
76
49
0
60
60
65
70
75
80
85
65
70
75
80
85
Coverage (% of eligible population less than 5 years since last adequate test)
Source: KC53, Health and Social Care Information Centre.
90
Figure 3a: Cervical screening – Five year coverage of the target age group (25-64)
Primary Care Organisation, England, 31st March 2013
Source: KC53, Health and Social Care Information Centre.
Figure 4: Number of women aged 25-64 invited for screening, by age
England, 2004-05 to 2012-13
Millions
5.0
4.5
4.69
4.24
4.15
4.0
3.5
3.0
25-64
2.5
50-64
2.0
25-49
1.5
1.0
0.5
0.0
2004-05
2005-06
2006-07
2007-08
Source: KC53, Health and Social Care Information Centre.
2008-09
2009-10
2010-11
2011-12
2012-13
Figure 5: Number of women tested, by age
England from 2004-05 to 2012-13
Millions
4.0
3.56
3.5
3.28
3.32
3.0
2.5
25-64
2.0
25-49
1.5
50-64
1.0
0.5
0.0
2004-05
2005-06
2006-07
2007-08
Source: KC53, Health and Social Care Information Centre.
2008-09
2009-10
2010-11
2011-12
2012-13
Figure 6: Cervical screening – Test results showing a high-grade abnormality as a
percentage of all test results, by age group
England 2012-13
Age
60-64
0.39
55-59
0.41
50-54
0.45
45-49
0.53
40-44
0.74
35-39
1.07
30-34
1.67
25-29
3.08
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Percent
Source: KC53, Health and Social Care Information Centre.
Figure 7: Cervical screening – Percentage of tests for women aged 25-64 with an abnormal result
England by Primary Care Organisation (PCO), 2012-13
Source: KC53, Health and Social Care Information Centre.
Figure 8: Cervical Screening – Time from screening to receipt of results as measured
by expected date of delivery of result letter (eligible women aged 25–64 years),
percentage received within 2 weeks: England by reporting region, 2012-13
England - 97.8
NEYH
97.1
North-East
North
East
95.9
Yorkshire&&the
theHumber
Humber
Yorkshire
97.7
North West
98.0
East Midlands
98.0
West Midlands
97.4
East of England
99.4
London
97.6
South East
97.1
South
South Central
Central
97.7
SouthEast
East Coast
Coast
South
96.6
South West
98.6
70
Reporting Region
75
80
85
90
SHA
Source: National Cancer Screening Statistics VSA15 Report, HSCIC ‘Open Exeter’ system (NHAIS).
95
100
Percent
Figure 9: Recall status for women with mild or borderline screening results
England, 2011-12 and 2012-13
Percent
Percent
90
90
80
80
83.6
70
70
70.4
60
Repeat (R)
72.9
60
50
50
40
43.7
30
33.2
20
10
Normal (A)
26.0
23.1
40
30
26.1
20
10
3.6
Suspend (S)
7.9
8.5
1.0
0
0
Borderline changes
(2011-12)
Borderline changes
(2012-13)
Source: KC53, Health and Social Care Information Centre.
Mild dyskaryosis
(2011-12)
Mild dyskaryosis
(2012-13)
Figure 10: Cervical cytology – Percentages of samples from GP & NHS Community
Clinics found to be inadequate, from women aged 25-64
England, 2002-03 to 2012-13
Percent
10
9.4
9
8
7
6
5
4
3
2.2
2
1
0
2002-03
2003-04
2004-05
2005-06
2006-07
2007-08
© Data prior to 2005, re-used with the permission of the Department of Health.
Source: KC61, Health and Social Care Information Centre.
2008-09
2009-10
2010-11
2011-12
2012-13
Figure 11: Cervical cytology – Percentage of samples from GP & NHS Community
Clinics found to be inadequate, for women aged 25-64, by laboratory
England, 2012-13
Number of laboratories
35
30
25
20
15
10
5
6
34
27
15
1
4
0
0
1
2
3
4
% Inadequate
Source: KC61, Health and Social Care Information Centre.
5
6
7
8
Figure 12: Outcome of referral following non-negative test result (persistent or with
positive HPV test)
England, April 2012 to June 2012
Cervical Cancer
0.1%
CIN3 or
Adenocarcinoma
in situ
6.8%
CIN2
10.4%
CIN1
26.3%
Other
56.3%
Non Cervical
Cancer
0.0%
Source: KC61, Health and Social Care Information Centre.
Figure 13: Outcome of referral following single occurrence of potentially
significant abnormality
England, April 2012 to June 2012
Non Cervical
Cancer
0.5%
Other
8.1%
Cervical Cancer
2.5%
CIN1
8.0%
CIN2
23.8%
Source: KC61, Health and Social Care Information Centre.
CIN3 or
Adenocarcinoma
in situ
57.2%
Figure 14: Positive Predictive Value, by laboratory
England, April 2012 to June 2012
Number of
Laboratories
40
35
30
25
20
15
10
5
1
7
11
22
34
7
5
0
50
55
60
65
70
75
80
85
Positive Predictive Value (%)
Source: KC61, Health and Social Care Information Centre.
90
95
100
Figure 15: Referral Value, by laboratory
England, April 2012 to June 2012
Number of
Laboratories
35
30
25
20
15
10
5
9
27
27
14
3
1
4
1
1
0
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
Referral Value
Source: KC61, Health and Social Care Information Centre.
4.0
4.5
5.0
5.5
6.0
6.5
Figure 16: Women referred to colposcopy: time from referral to first offered
appointment by indication
England, 2012-13
Source: KC65, Health and Social Care Information Centre.
Figure 17: Biopsies taken at colposcopy – time from biopsy until patient informed
of result (4 month sample)
England, 2012-13
Percent
60
50
40
30
20
10
38.4
45.2
13.7
less than
or equal to
2 weeks
more than
2 weeks up
to 4 weeks
more than
4 weeks up
to 8 weeks
1.7
1.1
0
Weeks
Source: KC65, Health and Social Care Information Centre.
more than
8 weeks up
to 12
weeks
over 12
weeks